Skip to main content
RXRX logo

RXRX · Recursion Pharmaceuticals, Inc. · Held by Funds

Track RXRX — free
$3.70 +0.12 (+3.35%) At close · Oct 23
Market Cap
$1.98B
Shares
535.34M
Volume · Oct 23 19.08M Avg daily vol (3M) 21.75M

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of RXRX by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 21.53% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 3.20% 17,153,942
Index ETFs 18.33% 98,127,655
Active ETFs 6.44% 34,466,609
Active funds 3.32% 17,753,215
Unclassified 0.07% 365,522
All registered funds 31.36% 167,866,943
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding RXRX

185 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 185 positions
Key facts CIK 1601830 CUSIP 75629V104 13F (30d) 51 filings 51 filers Visit website Investor relations